3George JN,Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenie purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood, 1996, 88(1) :3-40.
4Mazzucconi MG, Fazi P,Bcrnasconi S,et al. Therapy with high- dose dcxamcthasonc (HD-DXM) in previously untreated patients affecled by idiopathic thrombocytopcnic purpura:a GIMEMA experience. Blood,2007,109 (4) : 1401-1407.
5Ancona KG, Parker RI, Atlas iMP, et al. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol, 2002,24 ( 7 ) : 540- 544.
6BCSH. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol,2003,120 ( 4 ) :574-596.
7Jin F, Balthasar JP. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura. Hum Immunol, 2005,66 (4) :403-410.
8Park-Min Kit, Serbina NV, Yang W, et al. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity, 2007,26( 1 ) :67-78.
9Lusher JM, Warrier I. Use of intravenous gamma globulin in children and adolescents with idiopathic thromboeytopenie purpura and other immune thromboeytopenias. Am J Med,1987,83 (4A) : 10-16.
10Pcterlana D, Puccctti A, Simconi S, et al. Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis:report of four cases. Clin Rheumatol,2005,24( 1 ) :18-21.
